Dosage of botulinum toxin in patients undergoing treatment for hemifacial spasm: is there modification during follow-up?
Background The movement disorder known as hemifacial spasm is characterized by involuntary contractions of the muscles that are innervated by the facial nerve. The treatment of choice for this condition is botulinum toxin injections.
Saved in:
| Main Authors: | Fátima de Menezes Dantas, Felipe Olobardi Freire, Agábio Diógenes Pessoa Neto, Clécio de Oliveira Godeiro Júnior, Rodrigo Alencar e Silva |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2025-01-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1793935 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience Toxina botulínica tipo A no tratamento do espasmo hemifacial: 11 anos de experiência
by: Egberto Reis Barbosa, et al.
Published: (2010-08-01) -
Efficacy of isolated periocular botulinum toxin A injections versus periocular and adjunctive lower facial injections in hemifacial spasm: a randomized, controlled, noninferiority, crossover trial
by: Akarawit Eiamsamarng, et al.
Published: (2025-12-01) -
Botulinum Toxin in Oculoplasty: An Overview
by: Sindhuja Murugesan, et al.
Published: (2024-09-01) -
Toxina botulínica no blefaroespasmo, no espasmo hemifacial e na distonia cervical: resultados em 33 pacientes Botulinum toxin in blepharospasm, hemifacial spasm and cervical dystonia: results in 33 patients
by: Sérgio Ap. Novis, et al.
Published: (1995-09-01) -
A 12-Week Prospective, Double-Blind, Multicenter, Randomized Study Comparing 100 Units of Abobotulinum Toxin Type A (Dysport<sup>®</sup>) and 33.33 Units of Neubotulinum Toxin Type A (Neuronox<sup>®</sup>) for the Treatment of Hemifacial Spasm
by: Subsai Kongsaengdao, et al.
Published: (2025-04-01)